NL-OMON24957已完成不适用
Attention Bias Modification Training for Major Depressive Disorder: A Randomized Controlled Trial
Pro Persona, Center for Mental Health Care, Nijmegen, The NetherlandsWolfheze 2, 6874 Wolfheze0 个研究点目标入组 126 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A diagnosis of major depressive disorder, first or recurrent according to the DSM- IV-TR, as assessed with the MINI Neuropsychiatric Interview
- •Age: between 18-65 years
排除标准
- •Any psychotic disorder (current or previous)
- •Current mania or hypomania or a history of bipolar disorder
研究者
相似试验
进行中（未招募）
1 期
Study to compare the safety and efficacy of Omadacycline versus Levofloxacin for adults with acute pyelonephritisAcute PyelonephritisMedDRA version: 20.1Level: LLTClassification code 10001032Term: Acute pyelonephritisSystem Organ Class: 100000004862EUCTR2018-000037-13-LVParatek Pharma, LLC, a wholly-owned subsidiary of Paratek Pharmaceuticals, Inc.200
Unknown
2 期
Safety, Pharmacokinetics, Pharmacodynamics and Efficacy study of MRG-001 on Severe and Critical SARS-CoV-2CTRI/2022/01/039274Medregen LLC
招募中
2 期
Investigating Novel Pharmacological Treatments for Anorexia Nervosa - A Clinical TrialMental Health - Eating disordersAnorexia nervosaACTRN12623001019695Monash University100
进行中（未招募）
1 期
Therapeutics for Inpatients with COVID-19 (TICO)EUCTR2020-003278-37-GBReagents of the University of Minnesota1,000
进行中（未招募）
1 期
Therapeutics for Inpatients with COVID-19 (TICO)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-003278-37-ITIVERSITY COLLEGE LONDO2,000